A Study of Ganfort Versus Duotrav in Patients With Primary Open Angle Glaucoma or Ocular Hypertension

Launched by MINISTRY OF HEALTH, MALAYSIA · Jul 22, 2010

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Visual acuity 6/60 or better
• • 2. Patients who are controlled (IOP \< 21 mmHg) on non-fixed combination of Latanoprost \& Timolol for at least 3 months before the baseline visit and
• • 3. Patients on mono-therapy either Latanoprost or Timolol who are eligible for dual therapy being not satisfactorily controlled (IOP\>21mmHG)
• Exclusion Criteria:
• • 1. Angle closure glaucoma
• • 2. Neovascular Galucoma
• • 3. Secondary open angle glaucoma
• • 4. Ocular infection/inflammation within 3 months
• • 5. Ocular surgery within 3 months
• • 6. History of Refractive surgery
• • 7. Argon laser trabeculoplasty/Selective laser trabeculoplasty
• • 8. Pregnancy/nursing
• • 9. Hypersensitivity to benzalkonium chloride or to any other components of the trial drugs solution.
• • 10. Patients in whom beta-blockers are contraindicated
• • 11. Patients on any drugs known to affect IOP.